Purpose: To estimate the dosimetric impact of residual setup errors on parotid sparing in head-and-neck (H&N) intensity-modutated treatments and to evaluate the effect of employing an PRV (planning organ-at-risk volume) margin for the parotid gland. Patients and Methods: Ten patients treated for H&N cancer were considered. A nine-beam intensity-modutated radiotherapy (IMRT) was planned for each patient. A second optimization was performed prescribing dose constraint to the PRV of the parotid gland. Systematic setup errors of 2 mm, 3 mm, and 5 mm were simulated. The dose-volume histograms of the shifted and reference plans were compared with regard to mean parotid gland dose (MPD), normal-tissue complication probability (NTCP), and coverage of the clinical target volume (V(95%) and equivalent uniform dose [EUD]); the sensitivity of parotid sparing on setup error was evaluated with a probability-based approach. Results: MPD increased by 3.4%/mm and 3.0%/mm for displacements in the craniocaudal and lateral direction and by 0.7%/mm for displacements in the anterior-posterior direction. The probability to irradiate the parotid with a mean dose > 30 Gy was > 50%, for setup errors in cranial and lateral direction and < 10% in the anterior-posterior direction. The addition of a PRV margin improved parotid sparing, with a relative reduction in NTCP of 14%. The PRV margin compensates for setup errors of 3 mm and 5 mm (MPD <= 30 Gy in 87% and 60% of cases), without affecting clinical target volume coverage (V(95%) and EUD variations < 1% and < 1 Gy). Conclusion: The parotid gland is more sensitive to craniocaudal and lateral displacements. A setup error of 2 mm guarantees an MPD : 30 Gy in most cases, without adding a PRV margin. If greater displacements are expected/accepted, an adequate PRV margin could be used to meet the clinical parotid gland constraint of 30 Gy, without affecting target volume coverage.

Impact of Residual Setup Error on Parotid Gland Dose in Intensity-Modulated Radiation Therapy with or without Planning Organ-at-Risk Margin / Delana, A; Menegotti, L; Bolner, A; Tomio, L; Valentini, A; Lohr, F; Vanoni, V. - In: STRAHLENTHERAPIE UND ONKOLOGIE. - ISSN 0179-7158. - 185:7(2009), pp. 453-459. [10.1007/s00066-009-1888-9]

Impact of Residual Setup Error on Parotid Gland Dose in Intensity-Modulated Radiation Therapy with or without Planning Organ-at-Risk Margin

Lohr F;
2009

Abstract

Purpose: To estimate the dosimetric impact of residual setup errors on parotid sparing in head-and-neck (H&N) intensity-modutated treatments and to evaluate the effect of employing an PRV (planning organ-at-risk volume) margin for the parotid gland. Patients and Methods: Ten patients treated for H&N cancer were considered. A nine-beam intensity-modutated radiotherapy (IMRT) was planned for each patient. A second optimization was performed prescribing dose constraint to the PRV of the parotid gland. Systematic setup errors of 2 mm, 3 mm, and 5 mm were simulated. The dose-volume histograms of the shifted and reference plans were compared with regard to mean parotid gland dose (MPD), normal-tissue complication probability (NTCP), and coverage of the clinical target volume (V(95%) and equivalent uniform dose [EUD]); the sensitivity of parotid sparing on setup error was evaluated with a probability-based approach. Results: MPD increased by 3.4%/mm and 3.0%/mm for displacements in the craniocaudal and lateral direction and by 0.7%/mm for displacements in the anterior-posterior direction. The probability to irradiate the parotid with a mean dose > 30 Gy was > 50%, for setup errors in cranial and lateral direction and < 10% in the anterior-posterior direction. The addition of a PRV margin improved parotid sparing, with a relative reduction in NTCP of 14%. The PRV margin compensates for setup errors of 3 mm and 5 mm (MPD <= 30 Gy in 87% and 60% of cases), without affecting clinical target volume coverage (V(95%) and EUD variations < 1% and < 1 Gy). Conclusion: The parotid gland is more sensitive to craniocaudal and lateral displacements. A setup error of 2 mm guarantees an MPD : 30 Gy in most cases, without adding a PRV margin. If greater displacements are expected/accepted, an adequate PRV margin could be used to meet the clinical parotid gland constraint of 30 Gy, without affecting target volume coverage.
2009
185
7
453
459
Impact of Residual Setup Error on Parotid Gland Dose in Intensity-Modulated Radiation Therapy with or without Planning Organ-at-Risk Margin / Delana, A; Menegotti, L; Bolner, A; Tomio, L; Valentini, A; Lohr, F; Vanoni, V. - In: STRAHLENTHERAPIE UND ONKOLOGIE. - ISSN 0179-7158. - 185:7(2009), pp. 453-459. [10.1007/s00066-009-1888-9]
Delana, A; Menegotti, L; Bolner, A; Tomio, L; Valentini, A; Lohr, F; Vanoni, V
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1172407
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 16
social impact